Brimonidine tartrate
- Level
- Commodity
- Parent
- 51241100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51241131This classification denotes an alpha-adrenergic agonist with the molecular formula C11H10BrN5.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4S9CL2DY2H, chemically known as 6-quinoxalinamine, 5-bromo-n-(4,5-dihydro-1h-imidazol-2-yl)- (9ci) but generally known as brimonidine tartrate, which bears US NIH Compound Identifier 2435. European Medicines Agency schedules Brimonidine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13122MIG. Most nations schedule brimonidine tartrate under HS 29332990 and SITC 51573. As of Q4 2014, BRIMONIDINE TARTRATE remains the US FDA Preferred Term for this commodity. Brimonidine tartrate bears US NLM identifiers UMLS ID C0077768 and NCI Concept Code C47419. SMILES: C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O.
Same parent
Under 51241100 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51240000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.